Company Medicord Srl with Fiscal Code 15779740
recorded a turnover of 2024 of
62.573,
with a net profit of
31.987
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Medicord Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
62.291
34.919
38.424
41.707
48.782
43.390
51.180
46.489
53.066
62.573
Total Income - EUR
62.292
34.919
38.425
41.708
48.782
43.393
51.183
46.491
53.067
62.741
Total Expenses - EUR
22.291
23.368
16.293
13.901
16.304
17.134
16.910
22.864
23.997
28.910
Gross Profit/Loss - EUR
40.001
11.551
22.133
27.807
32.478
26.259
34.274
23.627
29.070
33.831
Net Profit/Loss - EUR
38.132
11.202
21.748
27.390
31.990
25.856
33.772
23.172
28.619
31.987
Employees
3
3
2
2
3
3
3
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 18.6%, from 53.066 euro in the year 2023, to 62.573 euro in 2024.
The Net Profit increased by 3.528 euro, from 28.619 euro in 2023, to 31.987 in the last year.
Check the financial reports for the company - Medicord Srl
Financial Rating - MEDICORD SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Medicord Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Medicord Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Medicord Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
39.481 euro in 2024 which includes Inventories of
0 euro, Receivables of
31.784 euro and cash availability of
7.697 euro.
The company's Equity was valued at
33.890 euro, while total Liabilities amounted to
5.591 euro.
Equity decreased by -1.793 euro, from 35.884 euro in 2023, to 33.890 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Medicord Srl